Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study
- PMID: 29927013
- PMCID: PMC6231089
- DOI: 10.1002/pon.4816
Depressive symptoms in relation to overall survival in people with head and neck cancer: A longitudinal cohort study
Abstract
Objective: The objective of the study is to investigate the relation between pretreatment depressive symptoms (DS) and the course of DS during the first year after cancer diagnosis, and overall survival among people with head and neck cancer (HNC).
Methods: Data from the Head and Neck 5000 prospective clinical cohort study were used. Depressive symptoms were measured using the Hospital Anxiety and Depression Scale (HADS) pretreatment, at 4 and 12-month follow-up. Also, socio-demographic, clinical, lifestyle, and mortality data were collected. The association between before start of treatment DS (HADS-depression > 7) and course (never DS, recovered from DS, or persistent/recurrent/late DS at 12-month follow-up) and survival was investigated using Cox regression. Unadjusted and adjusted analyses were performed.
Results: In total, 384 of the 2144 persons (18%) reported pretreatment DS. Regarding DS course, 63% never had DS, 16% recovered, and 20% had persistent/recurrent/late DS. People with pretreatment DS had a higher risk of earlier death than people without DS (hazard ratio (HR) = 1.65; 95% confidence interval (CI) 1.33-2.05), but this decreased after correcting for socio-demographic, clinical, and lifestyle-related factors (HR = 1.21; 95% CI 0.97-1.52). Regarding the course of DS, people with persistent/recurrent/late DS had a higher risk of earlier death (HR = 2.04; 95% CI 1.36-3.05), while people who recovered had a comparable risk (HR = 1.12; 95% CI 0.66-1.90) as the reference group who never experienced DS. After correcting for socio-demographic and clinical factors, people with persistent/recurrent/late DS still had a higher risk of earlier death (HR = 1.66; 95% CI 1.09-2.53).
Conclusions: Pretreatment DS and persistent/recurrent/late DS were associated with worse survival among people with HNC.
Keywords: cancer; depression; depressive symptoms; head and neck cancer; mortality; oncology; survival.
© 2018 The Authors. Psycho-Oncology Published by John Wiley & Sons Ltd.
References
-
- Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: A meta‐analysis. Cancer. 2009;115(22):5349‐5361. - PubMed
-
- Cuijpers P, Vogelzangs N, Twisk J, Kleiboer A, Li J, Penninx BW. Comprehensive meta‐analysis of excess mortality in depression in the general community versus patients with specific illnesses. Am J Psychiatry. 2014;171:453‐462. - PubMed
-
- Haisfield‐Wolfe ME, McGuire DB, Soeken K, Geiger‐Brown J, De Forge BR. Prevalence and correlates of depression among patients with head and neck cancer: A systematic review of implications for research. Oncol Nurs Forum. 2009;36:E107‐E125. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
